Vallance Jeffrey K H, Courneya Kerry S, Plotnikoff Ronald C, Yasui Yutaka, Mackey John R
Faculty of Physical Education and Recreation, Centre for Health Promotion Studies, School of Public Health, and Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada.
J Clin Oncol. 2007 Jun 10;25(17):2352-9. doi: 10.1200/JCO.2006.07.9988.
To determine the effects of breast cancer-specific print materials and step pedometers on physical activity (PA) and quality of life (QoL) in breast cancer survivors.
Breast cancer survivors (N = 377) were randomly assigned to receive one of the following: a standard public health recommendation for PA, previously developed breast cancer-specific PA print materials, a step pedometer, or a combination of breast cancer-specific print materials and step pedometers. The primary outcome was self-reported moderate/vigorous PA minutes per week. Secondary outcomes were QoL (Functional Assessment of Cancer Therapy-Breast), fatigue, self-reported brisk walking, and objective step counts. Assessments were conducted at baseline and postintervention (12 weeks).
Attrition was 10.3% (39 of 377). On the basis of linear mixed-model analyses, PA increased by 30 minutes/week in the standard recommendation group compared with 70 minutes/week in the print material group (mean difference, 39 minutes/week; 95% CI = -10 to 89; d = 0.25; P = .117), 89 minutes/week in the pedometer group (mean difference, 59 minutes/week; 95% CI, 11 to 108; d = 0.38; P = .017), and 87 minutes/week in the combined group (mean difference, 57 minutes/week; 95% CI, 8 to 106; d = 0.37; P = .022). For brisk walking minutes/week, all three intervention groups reported significantly greater increases than the standard recommendation group. The combined group also reported significantly improved QoL (mean difference, 5.8; 95% CI, 2.0 to 9.6; d = 0.33; P = .003) and reduced fatigue (mean difference, 2.3; 95% CI, 0.0 to 4.7; d = 0.25; P = .052) compared with the standard recommendation group.
Breast cancer-specific PA print materials and pedometers may be effective strategies for increasing PA and QoL in breast cancer survivors. A combined approach appears to be optimal.
ClinicalTrials.gov Identifier NCT00221221
确定乳腺癌专用印刷材料和计步器对乳腺癌幸存者身体活动(PA)和生活质量(QoL)的影响。
乳腺癌幸存者(N = 377)被随机分配接受以下其中一种:PA的标准公共卫生建议、先前制定的乳腺癌专用PA印刷材料、计步器,或乳腺癌专用印刷材料与计步器的组合。主要结局是自我报告的每周中等强度/剧烈强度PA分钟数。次要结局包括生活质量(癌症治疗功能评估-乳腺癌)、疲劳、自我报告的快走情况以及客观步数。在基线和干预后(12周)进行评估。
失访率为10.3%(377例中的39例)。基于线性混合模型分析,标准建议组的PA每周增加30分钟,而印刷材料组为每周增加70分钟(平均差值为39分钟/周;95%CI = -10至89;d = 0.25;P = 0.117),计步器组为每周增加89分钟(平均差值为59分钟/周;95%CI,11至108;d = 0.38;P = 0.017),联合组为每周增加87分钟(平均差值为57分钟/周;95%CI,8至106;d = 0.37;P = 0.022)。对于每周快走分钟数,所有三个干预组报告的增加量均显著高于标准建议组。与标准建议组相比,联合组还报告生活质量显著改善(平均差值为5.8;95%CI,2.0至9.6;d = 0.33;P = 0.003)且疲劳减轻(平均差值为2.3;95%CI,0.0至4.7;d = 0.25;P = 0.052)。
乳腺癌专用PA印刷材料和计步器可能是提高乳腺癌幸存者PA和QoL的有效策略。联合方法似乎是最佳的。
ClinicalTrials.gov标识符NCT00221221